Home » Topics » BioWorld Science

BioWorld Science
RSS

LPAR1 antagonist PIPE-791 promotes remyelination in multiple sclerosis

Nov. 15, 2021

Fitness cost of antibiotic-resistant mutants can be used to identify new combination therapies

Nov. 12, 2021

ITIH4 is a marker for early diagnosis of gastric cancer

Nov. 12, 2021

Opus Genetics licenses new preclinical program for inherited retinal disease

Nov. 12, 2021

Study shows gut microbiome changes may be effect, not cause, of autism spectrum disorders

Nov. 12, 2021

Rakovina presents data on in vitro activity of novel dual PARP-HDAC inhibitors

Nov. 12, 2021

Circulating levels of galectin-1 associated with lower kidney function

Nov. 12, 2021

Cannabigerol derivatives have anti-inflammatory, analgesic and antiobesity potential

Nov. 12, 2021

DDR1 promotes immune exclusion in tumors and it is a therapeutic target

Nov. 12, 2021

COVA1-18 demonstrates strong antiviral activity against SARS-CoV-2 in vivo

Nov. 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...